No effects of the COVID-19 pandemic on the prescription of insulin in Germany

AIMS: The aim of the study was to investigate the change of insulin doses in Germany between 2017 and 2021. METHODS: This retrospective study used data from the longitudinal prescription LRx database (IQVIA) and included all patients with at least two insulin prescriptions per year in 2017–2021. Cal...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacob, Louis, Yakkali, Balaji, Parekh, Mahir, Kostev, Karel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Primary Care Diabetes Europe. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035360/
https://www.ncbi.nlm.nih.gov/pubmed/35491317
http://dx.doi.org/10.1016/j.pcd.2022.04.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035360/
https://www.ncbi.nlm.nih.gov/pubmed/35491317
http://dx.doi.org/10.1016/j.pcd.2022.04.007

Ejemplares similares